|
|
Twelve years on dialysis treatment - Wawatay News |
|
|
Wawatay News
Constance Lake's Joseph John George has been living in Thunder Bay for about 12 years while undergoing dialysis treatment three days a week at the Thunder Bay Regional Health Sciences Centre. Constance Lake's Joseph John George misses his family in
|
|
|
NVS' Afinitor Gets FDA Panel Backing - Zacks.com |
|
|
Zacks.com
Novartis (NVS - Snapshot Report) recently received a positive recommendation from an advisory panel of the US Food and Drug Administration (FDA) for expanding the use of its renal cancer drug Afinitor. The approval is sought for the treatment of
|
|
FDA issues warning letter to Fresenius SE over dialysis tubing set - NephrOnline |
|
|
NephrOnline
According to the FDA letter, Fresenius implemented design changes to the dialysis tubing set, including a change in a tubing segment from thick wall to thin wall, before distributing the device in the United States. In November 2010, Fresenius issued a
|
|
|
New Book Defines Standards of Practice for Nephrology Nurses, Helps Ensure ... - PR Newswire (press release) |
|
|
PR Newswire (press release)
PITMAN, NJ, April 14, 2011 /PRNewswire/ -- With the rate of chronic kidney disease (CKD) in America spiking over the past two decades, the role of the nephrology nurse has become increasingly important as more lives are affected.
|
|
Proteon Therapeutics advances drug candidate, sale to Novartis - Bizjournals.com |
|
|
Bizjournals.com
... that permanently dilates blood vessels, is aimed at reducing the failure of hemodialysis access sites, which are the surgical connections of arteries and veins that allow patients to be hooked up to dialysis machines for periodic blood filtering. ...
Proteon Therapeutics Initiates Patient Enrollment in Phase 2 Clinical Study of
|
|
|
|
|
<< Start < Prev 961 962 963 964 965 966 967 968 969 970 Next > End >>
|
|
Page 964 of 2630 |